Is a complete CMMB research report available?

No complete published report is available for Chemomab Therapeutics Ltd. (CMMB) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Chemomab Therapeutics Ltd. (CMMB)

NASDAQ: CMMB · USD

$1.53

+0.07 (+4.8%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first CMMB analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	11M
Net income (ttm)	-7.4M
EPS (ttm)	-$1.07
Shares out	7.2M
Volume	57,702
Beta	0.64
Price target	$15.0	+880.4%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -7.4M
EPS (ttm): -$1.07
Market cap: 11M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All CMMB indicators

Market & fundamental data

Available fields

180

Groups with data

Currency

USD

Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001534248
Company name	Chemomab Therapeutics Ltd.
Country	Israel
Country code	US
Cusip	16385C203
Employees	3
Enterprise value	$3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US16385C2035
Last refreshed	2026-07-31
Market cap	$11M
Market cap category	Nano-Cap
Price	$1.53
Price currency	USD
Sector	Healthcare
Sector PE	45.51
Sector PE Fwd	24.23
Sic	2834
Symbol	CMMB
Website	https://www.chemomab.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-67.58%
FCF yield	-101.06%
P/B ratio	0.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-7.4M
Net Income Growth Quarters	10%
Net Income Growth Years	3%
Profit Per Employee	$-2.5M
ROA	-40.25
Roa5y	-37.62
ROCE	-65.5
ROE	-70.61
Roe5y	-68.61
ROIC	-46.36

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-64.93%
Cagr3y	-33.48%
Cagr5y	-53.08%
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$11.8M
Cash	$8M
Current Assets	$11.5M
Current Liabilities	$1.1M
Debt	$0
Equity	$10.7M
Liabilities	$1.1M
Long Term Assets	$334,000
Long Term Liabilities	$0
Net Cash	$8M
Net Cash By Market Cap	$73.01
Net Cash Growth	-21.69%
Net Debt Equity	$-0.75
Tangible Book Value	$10.7M
Tangible Book Value Per Share	$1.49
WACC	7.74

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10.31
Net Working Capital	$2.3M
Quick ratio	10.31
Working Capital	$10.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-38.23%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-64.91%
200-day SMA	1.95
3Y total return	-70.58%
50-day SMA	1.71
50-day SMA vs 200-day SMA	50under200
5Y total return	-97.73%
All Time High	316
All Time High Change	-99.52%
All Time High Date	2021-03-17
All Time Low	1.35
All Time Low Change	13.33%
All Time Low Date	2026-02-25
ATR	0.17
Beta	0.64
Beta1y	1.41
Beta2y	1.37
Ch YTD	-7.27
High	1.6
High52	4.55
High52 Date	2025-07-30
High52ch	-66.34%
Low	1.47
Low52	1.35
Low52 Date	2026-02-25
Low52ch	13.33%
Ma50ch	-10.32%
Premarket Change Percent	4.11
Premarket Price	$1.52
Premarket Volume	212
Price vs 200-day SMA	-21.42%
RSI	46.82
RSI Monthly	30.44
RSI Weekly	41.15
Sharpe ratio	-0.81x
Sortino ratio	-1.17
Total Return	-38.23%
Tr YTD	-7.27
Tr1m	-5.56%
Tr1w	9.29%
Tr3m	4.8%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Count Top	1
Analyst Price Target Top	$25
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.08
Operating Income	$-7.9M
Price target	$15
Price Target Change	$880
Price Target Change Top	$1,534

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,395,715%
Float Percent	88.82%
Shares Insiders	11.18%
Shares Institutions	11.93%
Shares Out	7,200,377
Shares Qo Q	2.02%
Shares Yo Y	38.23%
Short Ratio	0.49
Short Shares	1.89

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-11.8M
Adjusted OCF	-11,753,000
Average Volume	298,434.65x
Bv Per Share	1.49
CAPEX	$-3,000
Ch1m	-5.56
Ch1w	9.29
Ch1y	-64.91
Ch3m	4.8
Ch3y	-70.58
Ch5y	-97.73
Ch6m	-2.55
Change	4.79%
Change From Open	0
Close	1.46
Days Gap	4.79
Depreciation Amortization	74,250
Dollar Volume	88,284.1
Earnings Date	2026-08-13
Earnings Time	bmo
EBIT	$-7M
EBITDA	$-7M
EPS	$-1.07
F Score	1
FCF	$-11.1M
FCF EV Yield	-374.4x
FCF Per Share	$-1.55
Financing CF	7,157,000
Fiscal Year End	December
Founded	2,004
Investing CF	5,390,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Last Split Date	2025-08-26
Last Split Type	Reverse
Last10k Filing Date	2026-03-23
Ma150	1.7
Ma150ch	-9.89%
Ma20	1.69
Ma20ch	-9.36%
Net CF	1,417,000
Next Earnings Date	2026-08-13
Open	1.53
Optionable	No
Position In Range	48
Post Close	1.53
Postmarket Change Percent	-3.27
Postmarket Price	$1.48
Ppne	167,000
Pre Close	1.46
Price Date	2026-07-30
Ptbv Ratio	1.03
Relative Volume	0.19x
Share Based Comp	623,000
Tr6m	-2.55%
Volume	57,702

Chemomab Therapeutics Ltd. (CMMB)

Coverage state: Market snapshot only — no published research

Generate the first CMMB analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · CMMB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CMMB indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on CMMB

Frequently asked questions